Literature DB >> 26047605

MiR-503 inhibited cell proliferation of human breast cancer cells by suppressing CCND1 expression.

Jianting Long1, Caiwen Ou2, Haoming Xia3, Yifan Zhu3, Dayue Liu4.   

Abstract

Breast cancer is one of the most common malignancies and a major cause of cancer-related mortality all over the world. A growing body of reports revealed that microRNAs play essential roles in the progression of cancers. Aberrant expression of miR-503 has been reported in several kinds of cancer. The aim of the current study was to elucidate the role of miR-503 in the pathogenesis of breast cancer. In the present study, our results suggested that miR-503 expression was markedly downregulated in breast cancer tissues and cells. Overexpression of miR-503 in breast cancer cell lines reduced cell proliferation through inducing G0/G1 cell cycle arrest by targeting CCND1. Together, our findings provide new knowledge regarding the role of miR-503 in the progression of breast cancer and indicate the role of miR-503 as a tumor suppressor microRNA (miRNA) in breast cancer.

Entities:  

Keywords:  Breast cancer; CCND1; Cell cycle; Cell proliferation; miR-503

Mesh:

Substances:

Year:  2015        PMID: 26047605     DOI: 10.1007/s13277-015-3623-8

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  30 in total

1.  Prevalence and clinical outcomes of young breast cancer (YBC) patients according to intrinsic breast cancer subtypes: Single institutional experience in Korea.

Authors:  Yeon Hee Park; Su Jin Lee; Hyun Ae Jung; Sung Min Kim; Moon Jin Kim; Won Ho Kil; Jeong Eon Lee; Seok Jin Nam; Jin Seok Ahn; Young-Hyuck Im
Journal:  Breast       Date:  2015-02-24       Impact factor: 4.380

Review 2.  Quantitative proteomic strategies for the identification of microRNA targets.

Authors:  Chongyang Li; Qian Xiong; Jia Zhang; Feng Ge; Li-Jun Bi
Journal:  Expert Rev Proteomics       Date:  2012-10       Impact factor: 3.940

3.  Colorectal cancer statistics, 2014.

Authors:  Rebecca Siegel; Carol Desantis; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2014-03-17       Impact factor: 508.702

4.  Upregulation of miR-136 in human non-small cell lung cancer cells promotes Erk1/2 activation by targeting PPP2R2A.

Authors:  Sining Shen; Han Yue; Yin Li; Jianjun Qin; Ke Li; Ying Liu; Jiaxiang Wang
Journal:  Tumour Biol       Date:  2014-01

Review 5.  MicroRNA regulation by RNA-binding proteins and its implications for cancer.

Authors:  Marieke van Kouwenhove; Martijn Kedde; Reuven Agami
Journal:  Nat Rev Cancer       Date:  2011-08-05       Impact factor: 60.716

6.  MiR-503 targets PI3K p85 and IKK-β and suppresses progression of non-small cell lung cancer.

Authors:  Yi Yang; Lei Liu; Ying Zhang; Hongyu Guan; Jueheng Wu; Xun Zhu; Jie Yuan; Mengfeng Li
Journal:  Int J Cancer       Date:  2014-03-27       Impact factor: 7.396

7.  MicroRNA-27b suppresses growth and invasion of NSCLC cells by targeting Sp1.

Authors:  Jun Jiang; Xiaojuan Lv; Liang Fan; Guodong Huang; Yan Zhan; Mengyi Wang; Hongda Lu
Journal:  Tumour Biol       Date:  2014-07-11

8.  Age at diagnosis in relation to survival following breast cancer: a cohort study.

Authors:  Jasmine Brandt; Jens Peter Garne; Ingrid Tengrup; Jonas Manjer
Journal:  World J Surg Oncol       Date:  2015-02-07       Impact factor: 2.754

9.  MiR-25 promotes ovarian cancer proliferation and motility by targeting LATS2.

Authors:  Shujun Feng; Wenjing Pan; Ye Jin; Jianhua Zheng
Journal:  Tumour Biol       Date:  2014-09-02

Review 10.  The microRNA-200 family: small molecules with novel roles in cancer development, progression and therapy.

Authors:  Brock Humphries; Chengfeng Yang
Journal:  Oncotarget       Date:  2015-03-30
View more
  27 in total

1.  FARNA: knowledgebase of inferred functions of non-coding RNA transcripts.

Authors:  Tanvir Alam; Mahmut Uludag; Magbubah Essack; Adil Salhi; Haitham Ashoor; John B Hanks; Craig Kapfer; Katsuhiko Mineta; Takashi Gojobori; Vladimir B Bajic
Journal:  Nucleic Acids Res       Date:  2017-03-17       Impact factor: 16.971

Review 2.  Regulation of epithelial-mesenchymal transition through microRNAs: clinical and biological significance of microRNAs in breast cancer.

Authors:  Fu Peng; Liang Xiong; Hailin Tang; Cheng Peng; Jianping Chen
Journal:  Tumour Biol       Date:  2016-09-19

3.  MicroRNA-503 serves an oncogenic role in retinoblastoma progression by directly targeting PTPN12.

Authors:  Yang Cheng; Wei Liu
Journal:  Exp Ther Med       Date:  2019-07-19       Impact factor: 2.447

4.  Identification of key differentially expressed MicroRNAs in cancer patients through pan-cancer analysis.

Authors:  Yu Hu; Hayley Dingerdissen; Samir Gupta; Robel Kahsay; Vijay Shanker; Quan Wan; Cheng Yan; Raja Mazumder
Journal:  Comput Biol Med       Date:  2018-10-22       Impact factor: 4.589

5.  Identification of cyclin D1 as a major modulator of 3-nitropropionic acid-induced striatal neurodegeneration.

Authors:  Paula Dietrich; Shanta Alli; Megan K Mulligan; Rachel Cox; David G Ashbrook; Robert W Williams; Ioannis Dragatsis
Journal:  Neurobiol Dis       Date:  2021-12-03       Impact factor: 5.996

6.  An integrative transcriptomics approach identifies miR-503 as a candidate master regulator of the estrogen response in MCF-7 breast cancer cells.

Authors:  Jeanette Baran-Gale; Jeremy E Purvis; Praveen Sethupathy
Journal:  RNA       Date:  2016-08-18       Impact factor: 4.942

7.  MicroRNA-503 inhibits the proliferation and invasion of breast cancer cells via targeting insulin-like growth factor 1 receptor.

Authors:  Jingwang Yan; Yonghuan Xu; Haipeng Wang; Taiping Du; Hao Chen
Journal:  Mol Med Rep       Date:  2017-06-20       Impact factor: 2.952

8.  MiR-503 inhibits hepatocellular carcinoma cell growth via inhibition of insulin-like growth factor 1 receptor.

Authors:  Yao Xiao; Qinggang Tian; Jiantai He; Ming Huang; Chao Yang; Liansheng Gong
Journal:  Onco Targets Ther       Date:  2016-06-15       Impact factor: 4.147

9.  MicroRNA-10a suppresses breast cancer progression via PI3K/Akt/mTOR pathway.

Authors:  Kongliang Ke; Tingting Lou
Journal:  Oncol Lett       Date:  2017-09-14       Impact factor: 2.967

10.  MiR-503 modulates epithelial-mesenchymal transition in silica-induced pulmonary fibrosis by targeting PI3K p85 and is sponged by lncRNA MALAT1.

Authors:  Weiwen Yan; Qiuyun Wu; Wenxi Yao; Yan Li; Yi Liu; Jiali Yuan; Ruhui Han; Jingjin Yang; Xiaoming Ji; Chunhui Ni
Journal:  Sci Rep       Date:  2017-09-12       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.